Zydus Lifesciences wins final FDA approval for pulmonary hypertension drug
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has bagged final approval for Sildenafil for Oral Suspension USP 10 mg/ml, its generic for Revatio, from the United States Food and Drug Administration (FDA). According to Zydus Lifesciences, Sildenafil for oral suspension is approved for the treatment of high blood pressure in the lungs (pulmonary hypertension). By […]